2019-11-26 11:43:00 Jennifer Nessel, Assistant Editor Officials with the FDA have approved an expanded indication for insulin glargine injection (Toujeo, Sanofi) 300 Units/ml as a long-acting insulin to improve blood sugar control in adult and pediatric patients, age 6 years and older, with diabetes.1 The drug was previously approved by the agency for improving blood […]
